CDKN2B and endometriosis: This dysregulation could represent a critical node in the pathophysiology of endometriosis, particularly in its more invasive forms, and supports the potential of CDKN2B-AS1 not only as a genetic susceptibility marker but also as a potential therapeutic target in strategies aimed at modulating lncRNA activity.